Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02298153
Title A Study of MPDL3280A in Combination With INCB024360 in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab + Epacadostat

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Pinnacle Oncology Hematology Scottsdale Arizona 85258 United States Details
Yale University New Haven Connecticut 06510 United States Details
Harvard-Mass General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Washington Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field